Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease

Recruiting now

Conditions studied: Multi-modality Echocardiography, Primary Electrical Disease

In brief

From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded. Follow-up is until December 30, 2025 or endpoint event occurs. Endpoint events were defined as sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, ICD discharge events, all-cause death, heart failure and heart transplantation, which were statistically analyzed as a composite endpoint of cardiovascular analysis. The predictors of primary electrical disease and the risk factors for adverse cardiovascular events were analyzed.

Key facts

Study ID

NCT06172842

Run by

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

People needed

30

Starts

2024-01-01

Expected to finish

2026-10-01

Last updated by the study team

2024-01-23

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• primary electrical disease

You may not qualify if…

• Congenital heart disease, poor echocardiographic images, moderate or severe valvular disease

Where it is running

• Hanlu Lv — Guangzhou, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.